People

Sorry, no results were found.

Circles

Sorry, no results were found.

Posts

06/08/2023

Fill Finish Biopharmaceuticals market 2022 – Industry Growth by 2035

Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.

This evident surge in the demand for biologics fill finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.

The financial opportunity within the biologics fill / finish services market has been analysed across the following segments:

 Type of Packaging Container
 Ampoules
 Cartridges
 Syringes
 Vials

 Type of Biologic
 Antibodies
 Cell Therapies
 Gene Therapies
 Oligonucleotides
 Proteins / Peptides
 Vaccines
 Others

 Therapeutic Area
 Oncological Disorders
 Autoimmune Disorders
 Infectious Diseases
 Cardiovascular Disorders
 Other Disorders

 Scale of Operation
 Preclinical / Clinical
 Commercial

 Company Size
 Large
 Mid-sized
 Small

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
 AbbVie Contract Manufacturing
 Asymchem
 BioReliance
 Boehringer Ingelheim BioXcellence
 Catalent Biologics
 Charles River Laboratories
 Fareva
 Fresenius Kabi
 Glaxo SmithKline
 Hetero Drugs
 Intas Pharmaceuticals
 Lonza
 Patheon
 Pierre Fabre
 Recipharm
 Samsun Biologics
 Syngene
 Takara Bio
 Wacker Biotech
 WuXi AppTec
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Biologics Fill / Finish Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America

7. Biologics Fill / Finish Service Providers in Europe

8. Biologics Fill / Finish Service Providers in Asia-Pacific

9. Recent Partnerships

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish

14. Regional Capability Assessment

15. Market Sizing and Opportunity Analysis

16. Future Growth Opportunities

17. Case Study: Robotic Systems in Fill / Finish Operations

18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish

19. Concluding Remarks

20. Executive Insights

21. Appendix 1: Tabulated Data

22. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market
Modular facility manufacturers market

Cell therapy manufacturing market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#biologics #fillfinish #fillfinishservices #MarketResearch #MarketInsights


Biologics fill / finish services market, driven by over 175 companies and 350+ fill / finish facilities, is expected to grow at a CAGR of 10% in the coming decade

www.rootsanalysis.com

06/06/2023

Lab Automation market Analysis and Trends by 2022-2035

The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.
 A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
 A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
 An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
 A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Stage of Automation
 Pre-Analytical Stage
 Analytical Stage
 Post-Analytical Stage
 Total Lab Automation
 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments
 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users
 Key Geographical Region
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key companies covered in the report
 Abbott
 Anton Paar
 BD
 Beckman Coulter
 ERWEKA
 Leuze
 Ortho Clinical Diagnostics
 Pall Corporation
 PerkinElmer
 Roche Diagnostics
 Siemens Healthineers
 SYSTAG

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html

You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market

Global Antibiotics Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#Labautomation #Laboratoryautomation #LaboratoryautomationSystem #MarketResearch #MarketInsights

06/02/2023

Organ on a Chip market Share, Growth Analysis by 2035

With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry.

Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.

By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:
 Type of Product
 Organ(s) based
 Disease(s) based

 Type of Application Area
 Drug Discovery and Toxicity Testing
 Cancer Research
 Tissue Engineering and Regenerative Medicine
 Stem Cell Research

 Purpose
 Research Use
 Therapy Development

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)

The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:
 BEOnChip
 Dynamic42
 Emulate
 MIMETAS
 SynVivo
 TissUse
 uFluidix

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

1. Organ-on-Chip: Market Landscape

2. Organ-on-Chip Developers: Company Profiles

3. Patent Analysis

4. Brand Positioning Matrix

5. Academic Grants Analysis

6. Partnerships and Collaborations

7. Funding and Investment Analysis

8. Case Study: Scaffold-Free 3D Cell Culture Systems

9. Organ-on-Chip: Market Forecast and Opportunity Analysis

10. Conclusion

14. Executive Insights

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

You may also be interested in the following titles:
Blockchain Technology in Healthcare Market

Long-Acting Drug Delivery Technologies and Services Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#microfluidics #microfluidicchips #microphysiologicalsystems #MarketResearch #MarketInsights

The organ on a chip market, driven by the presence of more than 45 companies having over 400 patents, is anticipated to grow at more than 21% CAGR, till 2035

www.rootsanalysis.com

Videos

Sorry, no results were found.

People

Sorry, no results were found.

Circles

Sorry, no results were found.

Videos

Sorry, no results were found.

Posts

06/08/2023

Fill Finish Biopharmaceuticals market 2022 – Industry Growth by 2035

Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.

This evident surge in the demand for biologics fill finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.

The financial opportunity within the biologics fill / finish services market has been analysed across the following segments:

 Type of Packaging Container
 Ampoules
 Cartridges
 Syringes
 Vials

 Type of Biologic
 Antibodies
 Cell Therapies
 Gene Therapies
 Oligonucleotides
 Proteins / Peptides
 Vaccines
 Others

 Therapeutic Area
 Oncological Disorders
 Autoimmune Disorders
 Infectious Diseases
 Cardiovascular Disorders
 Other Disorders

 Scale of Operation
 Preclinical / Clinical
 Commercial

 Company Size
 Large
 Mid-sized
 Small

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
 AbbVie Contract Manufacturing
 Asymchem
 BioReliance
 Boehringer Ingelheim BioXcellence
 Catalent Biologics
 Charles River Laboratories
 Fareva
 Fresenius Kabi
 Glaxo SmithKline
 Hetero Drugs
 Intas Pharmaceuticals
 Lonza
 Patheon
 Pierre Fabre
 Recipharm
 Samsun Biologics
 Syngene
 Takara Bio
 Wacker Biotech
 WuXi AppTec
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Biologics Fill / Finish Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America

7. Biologics Fill / Finish Service Providers in Europe

8. Biologics Fill / Finish Service Providers in Asia-Pacific

9. Recent Partnerships

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish

14. Regional Capability Assessment

15. Market Sizing and Opportunity Analysis

16. Future Growth Opportunities

17. Case Study: Robotic Systems in Fill / Finish Operations

18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish

19. Concluding Remarks

20. Executive Insights

21. Appendix 1: Tabulated Data

22. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market
Modular facility manufacturers market

Cell therapy manufacturing market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#biologics #fillfinish #fillfinishservices #MarketResearch #MarketInsights


Biologics fill / finish services market, driven by over 175 companies and 350+ fill / finish facilities, is expected to grow at a CAGR of 10% in the coming decade

www.rootsanalysis.com

06/06/2023

Lab Automation market Analysis and Trends by 2022-2035

The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.
 A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
 A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
 An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
 A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Stage of Automation
 Pre-Analytical Stage
 Analytical Stage
 Post-Analytical Stage
 Total Lab Automation
 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments
 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users
 Key Geographical Region
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key companies covered in the report
 Abbott
 Anton Paar
 BD
 Beckman Coulter
 ERWEKA
 Leuze
 Ortho Clinical Diagnostics
 Pall Corporation
 PerkinElmer
 Roche Diagnostics
 Siemens Healthineers
 SYSTAG

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html

You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market

Global Antibiotics Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#Labautomation #Laboratoryautomation #LaboratoryautomationSystem #MarketResearch #MarketInsights

06/02/2023

Organ on a Chip market Share, Growth Analysis by 2035

With the introduction of FDA Modernization Act in 2021, the use of animal models for preclinical testing is being discouraged in the pharmaceutical industry.

Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.

By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:
 Type of Product
 Organ(s) based
 Disease(s) based

 Type of Application Area
 Drug Discovery and Toxicity Testing
 Cancer Research
 Tissue Engineering and Regenerative Medicine
 Stem Cell Research

 Purpose
 Research Use
 Therapy Development

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)

The “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” 2022-2035” report features the following companies, which we identified to be key players in this domain:
 BEOnChip
 Dynamic42
 Emulate
 MIMETAS
 SynVivo
 TissUse
 uFluidix

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

1. Organ-on-Chip: Market Landscape

2. Organ-on-Chip Developers: Company Profiles

3. Patent Analysis

4. Brand Positioning Matrix

5. Academic Grants Analysis

6. Partnerships and Collaborations

7. Funding and Investment Analysis

8. Case Study: Scaffold-Free 3D Cell Culture Systems

9. Organ-on-Chip: Market Forecast and Opportunity Analysis

10. Conclusion

14. Executive Insights

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

You may also be interested in the following titles:
Blockchain Technology in Healthcare Market

Long-Acting Drug Delivery Technologies and Services Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#microfluidics #microfluidicchips #microphysiologicalsystems #MarketResearch #MarketInsights

The organ on a chip market, driven by the presence of more than 45 companies having over 400 patents, is anticipated to grow at more than 21% CAGR, till 2035

www.rootsanalysis.com

05/25/2023

Filtration market 2022 – Industry Growth by 2035

To deal with the growing demand for biologics, single-use filtration technologies and advanced filtration systems, various industry stakeholders are engaged in the development of automated, efficient and user-friendly biopharmaceutical filtration systems

Roots Analysis has announced the addition of “Global Filtration Market (Focus on Biologics Manufacturing), 2023 – 2035” report to its list of offerings

The report features an extensive study on the current landscape and the likely future potential of global filtration market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:

 A general overview of the filtration systems, different types of filtration systems, advantages of biopharmaceutical filtration systems, challenges associated with biopharmaceutical filtration systems and applications of biopharmaceutical filtration.
 A detailed assessment of the overall market landscape of the companies offering biopharmaceutical filtration systems, based on several relevant parameters.
 A detailed competitiveness analysis of biopharmaceutical filtration system suppliers based in North America, Europe and Asia-Pacific
 Tabulated profiles of key players based in North America, Europe and Asia-Pacific that are engaged in supplying biopharmaceutical filtration systems (shortlisted based on strength of product portfolio, company size and availability of financial information).
 A detailed analysis of the recent developments taking place in the biopharmaceutical filtration domain. It includes various patents granted in this domain since 2019 and the mergers and acquisitions that have taken place in the recent past years
 An in-depth analysis of the global events taking place in the biopharmaceutical filtration domain, since 2018, based on various relevant parameters.

The financial opportunity within the biopharmaceutical market has been analyzed across the following segments:

 Type of Filtration System
 Depth Filtration Systems
 Tangential Flow Filtration Systems
 Membrane Filtration Systems
 Other Filtration Systems

 Type of Filter (based on use)
 Disposable / Single-use Filters
 Reusable / Multi-use Filters

 Type of Assembly
 Capsules
 Cartridges
 Others

 Type of Drug Product
 Antibodies
 Vaccines
 Recombinant Proteins
 Cell Therapies
 Gene Therapies
 Oligonucleotides
 Others

 Company Size
 Small
 Mid-sized
 Large

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World

Key Companies covered in the report
 Asahi Kasei
 Cobetter Filtration
 Corning
 Merck
 Pall
 Parker Hannifin
 Sartorius
 Thermo Fisher Scientific

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/global-filtration-market.html

You may also be interested in the following titles:
Gene Switch Market

Digital Biomanufacturing Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#filtersystems #filtrationmanufacturers #sterilization #MarketResearch #MarketInsights